Projects

What is a Project?
397 Projects found
No description specified

Programme: M-era.Net 3D4D2

Public web page: Not specified

Start date: 9th Aug 2021

End date: 8th Aug 2024

LEADER: StU (prof. B. Klumperman)

PARTNERS: StU & SU


OBJECTIVES:

• Optimization of antimalarial drug encapsulation for fast release.

• Development of transmission blocking drug encapsulation for slow release.


DELIVERABLES:

**07.2022 D ...

Programme: M-era.Net 3D4D2

Public web page: Not specified

Start date: 1st Jul 2021

End date: 1st Jan 2024

LEADER: prof. L-M. Birkholtz

PARTNERS: UP & WITS & SU & StU


OBJECTIVES:

• Evaluation of the ability of the novel polymer-drug systems to kill the transmissible gametocytes.

• Validation using treatment of anopheline mosquitoes in a membrane feeding assay.


...

Programme: M-era.Net 3D4D2

Public web page: Not specified

Start date: 1st Jul 2021

End date: 30th Jun 2024

No description specified

Programme: Independent Projects

Public web page: Not specified

This project collects and maintains minimum information metadata templates designed and used in the National NL-Bioimaging initiative. The templates are based on the REMBI standards and contribute to FAIR bioimaging data in the Netherlands, together with data management in the OMERO database.

WARNING: THIS IS A TEST PROJECT CREATED FOR TESTING THE UPLOAD TO FAIRDOMHUB USING seekr AND SEEK API

pISA-tree: Standard project directory tree

A set of batch files is used to create standard directory tree for research projects. Batch files are provided to make standardized nested directories in accordance with the ISA Abstract Model levels (Investigation/Study/Assay).

https://github.com/NIB-SI/pISA-tree

https://bio.tools/pisa-tree

Linked resources:

  • R support for pISA-tree DOI ...

Programme: NIBSys

Public web page: http://ablejec.nib.si/doc

No description specified

Programme: Independent Projects

Public web page: Not specified

LEADER: UL (prof. J.C. Simon)

PARTNERS: UL & IPF & SU & StU


OBJECTIVES:

• Validation of biocompatibility of the drug delivery systems with the skin.

• Testing of the drug delivery into and through the skin.


DELIVERABLES ...

Programme: M-era.Net 3D4D2

Public web page: Not specified

Start date: 1st Jul 2021

End date: 30th Jun 2024

No description specified

Programme: Independent Projects

Public web page: Not specified

No description specified

Programme: MIT Superfund Research

Public web page: Not specified

No description specified

Programme: Independent Projects

Public web page: Not specified

BBSRC sLoLa grantThe spread of antimicrobial resistance (AMR) is a slow-moving pandemic that has been identified by the WHO as one of the top 10 threats facing humanity. Plasmids and other MGEs play a key role in the dissemination of AMR, but we have only a rudimentary understanding of the factors that determine if and how MGEs spread through microbial communities. It is generally assumed that bacterial immune systems are a major determinant, but existing studies are limited to only a few stand-alone ...

Programme: MultiDefence - sLoLa

Public web page: Not specified

Towards the Digital Salmon: From a reactive to a pre-emptive research strategy in aquaculture (DigiSal)

Salmon farming in the future must navigate conflicting and shifting demands of sustainability, shifting feed prices, disease, and product quality. The industry needs to develop a flexible, integrated basis of knowledge for rapid response to new challenges. Project DigiSal will lay the foundations for a Digital Salmon: an ensemble of mathematical descriptions of salmon physiology, combining ...

The project brings comprehensive study of diversity in Clostridium beijerinckii, solvent-producing species with potential use in industrial biotechnology.

Programme: Clostridium beijerinckii

Public web page: Not specified

No description specified

Programme: Independent Projects

Public web page: Not specified

Andrew Millar's research group, University of Edinburgh

Rationale: Individuals with a cancer predisposition due to a mutation in the paradigm tumor suppressor gene RB1, have a high risk to develop the childhood cancer retinoblastoma (Rb). Biopsies are not possible in Rb, before treatment selection. Heritable Rb patients have also a high risk to develop other types of second primary, either childhood or adult, malignancies (SPMs), notably sarcomas and melanomas. Remarkably, SPMs are now the leading cause of death in heritable-Rb-survivors. Unfortunately, ...

LEADER: IPF (prof. A. Lederer)

PARTNERS: IPF & StU


OBJECTIVES:

• Determination of stability, degradation and drug release kinetics.

• Mathematical modelling of response to treatments of infectious diseases.


DELIVERABLES

10.2022 M 3.1 ...

Programme: M-era.Net 3D4D2

Public web page: Not specified

Start date: 1st Jul 2021

End date: 30th Jun 2024

Here we share resources and best practices to develop a disease map for COVID-19. The project is progressing as a broad community-driven effort. We aim to establish a knowledge repository on virus-host interaction mechanisms specific to the SARS-CoV-2. The COVID-19 Disease Map is an assembly of molecular interaction diagrams established based on literature evidence.

Investigation regarding the impact of periportal steatosis on selected parameters of drug metabolism.

No description specified

Programme: M-era.Net 3D4D2

Public web page: Not specified

Start date: 1st Jul 2021

End date: 30th Jun 2023

Cells of P. cordatum adapted to growth at 20 °C and constant light:dark conditions were shifted to growth at 26 °C and 30 °C, respectively, with similar illumination conditions. During exponential and stationary growth, cells were collected for transcriptomic, proteomic and metabolomic analyses.

Programme: Independent Projects

Public web page: Not specified

experimental data; middle ear transfer functions

Programme: Independent Projects

Public web page: https://www.ercd.net

By intelligent use of existing registries and health data, DeCipher aims to develop a data-driven framework to provide a personalized time-varying risk assessment for cancer initiation and identify subgroups of individuals and factors leading to similar disease progression. By unveiling structure hidden in the data, we will develop novel theoretically grounded machine learning methods for the analysis of large-scale registry and health data.DeCipher consists of an excellent multidisciplinary ...

Standard ASO design is based on the sequence complementarity of the oligo to its target. However, the degree of target knockdown that ASOs can achieve varies strongly between different ASOs having full complementarity to the target. To determine which factors affect the ASOs’ activity, Secarna has used a novel approach: the Company has designed and screened 51 multi-specific ASOs with a common target (IDO1, a gene involved in tryptophan metabolism), and varying numbers of diverse other targets ...

Programme: RNA-seq

Public web page: Not specified

No description specified

Programme: Independent Projects

Public web page: Not specified

Salmon farmed on modern feeds contains less of the healthy, long-chain fatty acids (EPA and DHA) than before. Up until the turn of the millennium, farmed salmon were fed fish oil as a replacement for their omega-3 rich natural prey. However, fish oil is now a scarce resource, and more than half of the fat in modern feeds comes from plant oils that are inexpensive, but devoid of long-chain omega-3 fatty acids. How can we increase the omega-3 content of salmon on sustainable feeds?

One option is ...

This is a sandbox where DigiSal members can learn to use the SEEK.

Tutorial document: http://tinyurl.com/seek-ds17

The SEEK is a web interface to a database of research "assets" organised in a hierarchical "ISA structure" (investigation-study-assay) [1]. These are further organised into projects and programmes.

  • Programme = Overarching research theme (The Digital Salmon)
  • Project = Research grant (DigiSal, GenoSysFat)
  • Investigation = a particular biological process, phenomenon or thing ...
Powered by
(v.1.15.0-pre)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH